Brian Corvese - Mar 9, 2022 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Stock symbol
INKT
Transactions as of
Mar 9, 2022
Transactions value $
$0
Form type
4
Date filed
3/11/2022, 03:09 PM
Previous filing
Feb 8, 2022
Next filing
Sep 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INKT Stock Option (Right to Buy) Award $0 +25K $0.00 25K Mar 9, 2022 Common Stock 25K $2.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.